Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Garlic Compound Effective Against Killer MRSA ‘Superbugs’ – New Evidence

23.12.2003


A compound extracted from garlic is effective against even the most antibiotic-resistant strains of MRSA, the killer ‘hospital superbug’, and can cure patients with MRSA-infected wounds within weeks, according to new research by microbiologist Dr Ron Cutler of the University of East London (UEL).


Garlic bulb



In a paper to be published in the New Year, Dr Cutler, an expert in the antimicrobial properties of plant extracts, claims that allicin - a compound that occurs naturally in garlic – kills not only established varieties of MRSA, but also destroys the new generation of ‘super-superbugs’ that have evolved resistance to Vancomycin and Glycopeptides, the powerful antibiotics widely considered to be the last line of defence against MRSA.

MRSA (Methicillin-resistant Staphylococcus aureus) now causes an estimated 2,000 deaths in UK hospitals each year mainly through secondary infection of surgical wounds. Though MRSA organisms can live harmlessly in humans and are carried in the nasal passages and on the skin, they can cause fatal infection in immune-suppressed patients, the elderly, the young and those with surgical implants.


Doctors have become increasingly alarmed over the past few months by the emergence in UK hospitals of new generations of resistant strains of MRSA known as VISAs, and GISAs (Vancomycin or Glycopeptide resistant Staphylococcus aureus). MRSA has also become endemic in many hospitals, especially in London and the South-East, prompting the NHS to review its hygiene procedures.

Dr Cutler, recently proved that allicin destroys the MRSA microbe in laboratory trials, has now teamed up with a new company, Allicin International, to develop topical treatments to prevent MRSA infection. The group have developed a nasal cream, oral capsules and soaps that have proved effective against both MRSA and GISA.

In partnership with colleagues in the NHS, Dr Cutler is now embarking on a major clinical trial involving around two hundred volunteers, including patients at several hospitals in London and the South East.

Dr Cutler said: "The trials we have conducted so far show that this formulation is highly effective against MRSA, and it could save many lives. This finding is backed up by initial findings a number of recent case studies. We have been trying to set up a clinical trial for many months now, and at last we have secured funding from sources including Allicin International.

“MRSA is causing a genuine crisis in our hospital system in Britain and worldwide. Antibiotics are increasingly ineffective, but we do have a powerful natural ally. Plant compounds have evolved over millions of years as chemical defence agents against infection. Garlic has been used in medicine for centuries, and it should be no surprise that it is effective against this very modern infection.”

The research on the laboratory effects of allicin on GISA was presented in part at the Institute of Biomedical Scientists congress in Birmingham, October 2003, and is being prepared for publication in the Journal of Biomedical Science, to appear in the New Year. A full clinical study involving the use of allicin to reduce nasal carriage in healthy volunteers, including in hospitals in London and South East England, is underway and initial results are due to be published in summer 2004.

Case Study: Deborah’s story
Deborah Brown (34), a probation service officer who lives in Rainham, Kent, contracted MRSA after a major spinal operation in November 2000.

The painful wounds on her spine failed to heal despite constant applications of both oral antibiotics and creams, which also failed to reduce the levels of MRSA in her tissue.

In December 2002, Deborah’s mother Pauline contacted Dr Cutler after seeing an item on TV about MRSA and received a course of Allimax cream and capsules by post. Within two months, the MRSA had mostly cleared from Deborah’s tissues and the wounds had begun to heal, allowing an operation to remove her spinal supports to be carried out in June 2003.

Deborah said: “The effect of the treatment was dramatic - I am making a good recovery now – but it was really awful at the time. Having weeping wounds on my back that never healed for two years was incredibly painful, and I became increasingly depressed as the MRSA didn’t respond to repeated courses of antibiotics. If my case helps to show that allicin works against MRSA then I am glad that something good might come of it.”

Patrick Wilson | alfa
Further information:
http://www.uel.ac.uk

More articles from Health and Medicine:

nachricht New evidence: How amino acid cysteine combats Huntington's disease
27.07.2016 | Johns Hopkins Medicine

nachricht Cord blood outperforms matched, unrelated donor in bone marrow transplant
27.07.2016 | University of Colorado Anschutz Medical Campus

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Self-assembling nano inks form conductive and transparent grids during imprint

Transparent electronics devices are present in today’s thin film displays, solar cells, and touchscreens. The future will bring flexible versions of such devices. Their production requires printable materials that are transparent and remain highly conductive even when deformed. Researchers at INM – Leibniz Institute for New Materials have combined a new self-assembling nano ink with an imprint process to create flexible conductive grids with a resolution below one micrometer.

To print the grids, an ink of gold nanowires is applied to a substrate. A structured stamp is pressed on the substrate and forces the ink into a pattern. “The...

Im Focus: The Glowing Brain

A new Fraunhofer MEVIS method conveys medical interrelationships quickly and intuitively with innovative visualization technology

On the monitor, a brain spins slowly and can be examined from every angle. Suddenly, some sections start glowing, first on the side and then the entire back of...

Im Focus: Newly discovered material property may lead to high temp superconductivity

Researchers at the U.S. Department of Energy's (DOE) Ames Laboratory have discovered an unusual property of purple bronze that may point to new ways to achieve high temperature superconductivity.

While studying purple bronze, a molybdenum oxide, researchers discovered an unconventional charge density wave on its surface.

Im Focus: Mapping electromagnetic waveforms

Munich Physicists have developed a novel electron microscope that can visualize electromagnetic fields oscillating at frequencies of billions of cycles per second.

Temporally varying electromagnetic fields are the driving force behind the whole of electronics. Their polarities can change at mind-bogglingly fast rates, and...

Im Focus: Continental tug-of-war - until the rope snaps

Breakup of continents with two speed: Continents initially stretch very slowly along the future splitting zone, but then move apart very quickly before the onset of rupture. The final speed can be up to 20 times faster than in the first, slow extension phase.phases

Present-day continents were shaped hundreds of millions of years ago as the supercontinent Pangaea broke apart. Derived from Pangaea’s main fragments Gondwana...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

GROWING IN CITIES - Interdisciplinary Perspectives on Urban Gardening

15.07.2016 | Event News

SIGGRAPH2016 Computer Graphics Interactive Techniques, 24-28 July, Anaheim, California

15.07.2016 | Event News

Partner countries of FAIR accelerator meet in Darmstadt and approve developments

11.07.2016 | Event News

 
Latest News

World first demo of labyrinth magnetic-domain-optical Q-switched laser

28.07.2016 | Information Technology

New material could advance superconductivity

28.07.2016 | Materials Sciences

CO2 can be stored underground for 10 times the length needed to avoid climatic impact

28.07.2016 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>